カテゴリー： Market Monitor Global, 世界, 医療/バイオ

オピエートきっ抗剤の世界市場見通し2023年-2029年

◆英語タイトル：Opiate Antagonist Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5835）

◆商品コード：MMG23JU5835
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Opiate Antagonist Market 調査レポートは次の情報を含め、グローバルにおけるのオピエートきっ抗剤市場規模と予測を収録しています。・世界のオピエートきっ抗剤市場：売上、2018年-2023年、2024年-2029年
・世界のオピエートきっ抗剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のオピエートきっ抗剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.4mg/ml」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

オピエートきっ抗剤のグローバル主要企業は、Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceuticals、 Cardinal Health、 Baxter Pharmaceutical、 Adapt Pharmaceuticals、 Dr. Reddy's Laboratories、 GIV Repack、 Intl Medication Systems、 Kaleo Pharma、 Mylan Institutional、 Perrigo Pharmaceuticals、 AuroMedics Pharma、 Somerset Pharma、 Akorn、 Alkermesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、オピエートきっ抗剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のオピエートきっ抗剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のオピエートきっ抗剤市場：タイプ別市場シェア、2022年
・0.4mg/ml、1mg/ml、2mg/ml

世界のオピエートきっ抗剤市場：用途別、2018年-2023年、2024年-2029年
世界のオピエートきっ抗剤市場：用途別市場シェア、2022年
・病院、診療所、薬局、家庭、その他

世界のオピエートきっ抗剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のオピエートきっ抗剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるオピエートきっ抗剤のグローバル売上、2018年-2023年
・主要企業におけるオピエートきっ抗剤のグローバル売上シェア、2022年
・主要企業におけるオピエートきっ抗剤のグローバル販売量、2018年-2023年
・主要企業におけるオピエートきっ抗剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceuticals、 Cardinal Health、 Baxter Pharmaceutical、 Adapt Pharmaceuticals、 Dr. Reddy's Laboratories、 GIV Repack、 Intl Medication Systems、 Kaleo Pharma、 Mylan Institutional、 Perrigo Pharmaceuticals、 AuroMedics Pharma、 Somerset Pharma、 Akorn、 Alkermes

*************************************************************

・調査・分析レポートの概要
オピエートきっ抗剤市場の定義
市場セグメント
世界のオピエートきっ抗剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のオピエートきっ抗剤市場規模
世界のオピエートきっ抗剤市場規模：2022年 VS 2029年
世界のオピエートきっ抗剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのオピエートきっ抗剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のオピエートきっ抗剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：0.4mg/ml、1mg/ml、2mg/ml
オピエートきっ抗剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、薬局、家庭、その他
オピエートきっ抗剤の用途別グローバル売上・予測

・地域別市場分析
地域別オピエートきっ抗剤市場規模 2022年と2029年
地域別オピエートきっ抗剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceuticals、 Cardinal Health、 Baxter Pharmaceutical、 Adapt Pharmaceuticals、 Dr. Reddy's Laboratories、 GIV Repack、 Intl Medication Systems、 Kaleo Pharma、 Mylan Institutional、 Perrigo Pharmaceuticals、 AuroMedics Pharma、 Somerset Pharma、 Akorn、 Alkermes
...

This report aims to provide a comprehensive presentation of the global market for Opiate Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opiate Antagonist. This report contains market size and forecasts of Opiate Antagonist in global, including the following market information:
Global Opiate Antagonist Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Opiate Antagonist market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
0.4 mg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Opiate Antagonist include Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health, Baxter Pharmaceutical, Adapt Pharmaceuticals, Dr. Reddy’s Laboratories, GIV Repack and Intl Medication Systems, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opiate Antagonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opiate Antagonist Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Opiate Antagonist Market Segment Percentages, by Type, 2022 (%)
0.4 mg/ml
1 mg/ml
2 mg/ml
Global Opiate Antagonist Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Opiate Antagonist Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Pharmacy
Home
Others
Global Opiate Antagonist Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Opiate Antagonist Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opiate Antagonist revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Opiate Antagonist revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sun Pharmaceutical Industries
Teva Pharmaceuticals
Cardinal Health
Baxter Pharmaceutical
Adapt Pharmaceuticals
Dr. Reddy’s Laboratories
GIV Repack
Intl Medication Systems
Kaleo Pharma
Mylan Institutional
Perrigo Pharmaceuticals
AuroMedics Pharma
Somerset Pharma
Akorn
Alkermes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opiate Antagonist, market overview.
Chapter 2: Global Opiate Antagonist market size in revenue.
Chapter 3: Detailed analysis of Opiate Antagonist company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opiate Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Opiate Antagonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opiate Antagonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opiate Antagonist Overall Market Size
2.1 Global Opiate Antagonist Market Size: 2022 VS 2029
2.2 Global Opiate Antagonist Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Opiate Antagonist Players in Global Market
3.2 Top Global Opiate Antagonist Companies Ranked by Revenue
3.3 Global Opiate Antagonist Revenue by Companies
3.4 Top 3 and Top 5 Opiate Antagonist Companies in Global Market, by Revenue in 2022
3.5 Global Companies Opiate Antagonist Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opiate Antagonist Players in Global Market
3.6.1 List of Global Tier 1 Opiate Antagonist Companies
3.6.2 List of Global Tier 2 and Tier 3 Opiate Antagonist Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Opiate Antagonist Market Size Markets, 2022 & 2029
4.1.2 0.4 mg/ml
4.1.3 1 mg/ml
4.1.4 2 mg/ml
4.2 By Type – Global Opiate Antagonist Revenue & Forecasts
4.2.1 By Type – Global Opiate Antagonist Revenue, 2018-2023
4.2.2 By Type – Global Opiate Antagonist Revenue, 2024-2029
4.2.3 By Type – Global Opiate Antagonist Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Opiate Antagonist Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Pharmacy
5.1.5 Home
5.1.6 Others
5.2 By Application – Global Opiate Antagonist Revenue & Forecasts
5.2.1 By Application – Global Opiate Antagonist Revenue, 2018-2023
5.2.2 By Application – Global Opiate Antagonist Revenue, 2024-2029
5.2.3 By Application – Global Opiate Antagonist Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Opiate Antagonist Market Size, 2022 & 2029
6.2 By Region – Global Opiate Antagonist Revenue & Forecasts
6.2.1 By Region – Global Opiate Antagonist Revenue, 2018-2023
6.2.2 By Region – Global Opiate Antagonist Revenue, 2024-2029
6.2.3 By Region – Global Opiate Antagonist Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Opiate Antagonist Revenue, 2018-2029
6.3.2 US Opiate Antagonist Market Size, 2018-2029
6.3.3 Canada Opiate Antagonist Market Size, 2018-2029
6.3.4 Mexico Opiate Antagonist Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Opiate Antagonist Revenue, 2018-2029
6.4.2 Germany Opiate Antagonist Market Size, 2018-2029
6.4.3 France Opiate Antagonist Market Size, 2018-2029
6.4.4 U.K. Opiate Antagonist Market Size, 2018-2029
6.4.5 Italy Opiate Antagonist Market Size, 2018-2029
6.4.6 Russia Opiate Antagonist Market Size, 2018-2029
6.4.7 Nordic Countries Opiate Antagonist Market Size, 2018-2029
6.4.8 Benelux Opiate Antagonist Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Opiate Antagonist Revenue, 2018-2029
6.5.2 China Opiate Antagonist Market Size, 2018-2029
6.5.3 Japan Opiate Antagonist Market Size, 2018-2029
6.5.4 South Korea Opiate Antagonist Market Size, 2018-2029
6.5.5 Southeast Asia Opiate Antagonist Market Size, 2018-2029
6.5.6 India Opiate Antagonist Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Opiate Antagonist Revenue, 2018-2029
6.6.2 Brazil Opiate Antagonist Market Size, 2018-2029
6.6.3 Argentina Opiate Antagonist Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Opiate Antagonist Revenue, 2018-2029
6.7.2 Turkey Opiate Antagonist Market Size, 2018-2029
6.7.3 Israel Opiate Antagonist Market Size, 2018-2029
6.7.4 Saudi Arabia Opiate Antagonist Market Size, 2018-2029
6.7.5 UAE Opiate Antagonist Market Size, 2018-2029
7 Opiate Antagonist Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Opiate Antagonist Major Product Offerings
7.1.4 Pfizer Opiate Antagonist Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Sun Pharmaceutical Industries
7.2.1 Sun Pharmaceutical Industries Company Summary
7.2.2 Sun Pharmaceutical Industries Business Overview
7.2.3 Sun Pharmaceutical Industries Opiate Antagonist Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Opiate Antagonist Revenue in Global Market (2018-2023)
7.2.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.3 Teva Pharmaceuticals
7.3.1 Teva Pharmaceuticals Company Summary
7.3.2 Teva Pharmaceuticals Business Overview
7.3.3 Teva Pharmaceuticals Opiate Antagonist Major Product Offerings
7.3.4 Teva Pharmaceuticals Opiate Antagonist Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceuticals Key News & Latest Developments
7.4 Cardinal Health
7.4.1 Cardinal Health Company Summary
7.4.2 Cardinal Health Business Overview
7.4.3 Cardinal Health Opiate Antagonist Major Product Offerings
7.4.4 Cardinal Health Opiate Antagonist Revenue in Global Market (2018-2023)
7.4.5 Cardinal Health Key News & Latest Developments
7.5 Baxter Pharmaceutical
7.5.1 Baxter Pharmaceutical Company Summary
7.5.2 Baxter Pharmaceutical Business Overview
7.5.3 Baxter Pharmaceutical Opiate Antagonist Major Product Offerings
7.5.4 Baxter Pharmaceutical Opiate Antagonist Revenue in Global Market (2018-2023)
7.5.5 Baxter Pharmaceutical Key News & Latest Developments
7.6 Adapt Pharmaceuticals
7.6.1 Adapt Pharmaceuticals Company Summary
7.6.2 Adapt Pharmaceuticals Business Overview
7.6.3 Adapt Pharmaceuticals Opiate Antagonist Major Product Offerings
7.6.4 Adapt Pharmaceuticals Opiate Antagonist Revenue in Global Market (2018-2023)
7.6.5 Adapt Pharmaceuticals Key News & Latest Developments
7.7 Dr. Reddy’s Laboratories
7.7.1 Dr. Reddy’s Laboratories Company Summary
7.7.2 Dr. Reddy’s Laboratories Business Overview
7.7.3 Dr. Reddy’s Laboratories Opiate Antagonist Major Product Offerings
7.7.4 Dr. Reddy’s Laboratories Opiate Antagonist Revenue in Global Market (2018-2023)
7.7.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.8 GIV Repack
7.8.1 GIV Repack Company Summary
7.8.2 GIV Repack Business Overview
7.8.3 GIV Repack Opiate Antagonist Major Product Offerings
7.8.4 GIV Repack Opiate Antagonist Revenue in Global Market (2018-2023)
7.8.5 GIV Repack Key News & Latest Developments
7.9 Intl Medication Systems
7.9.1 Intl Medication Systems Company Summary
7.9.2 Intl Medication Systems Business Overview
7.9.3 Intl Medication Systems Opiate Antagonist Major Product Offerings
7.9.4 Intl Medication Systems Opiate Antagonist Revenue in Global Market (2018-2023)
7.9.5 Intl Medication Systems Key News & Latest Developments
7.10 Kaleo Pharma
7.10.1 Kaleo Pharma Company Summary
7.10.2 Kaleo Pharma Business Overview
7.10.3 Kaleo Pharma Opiate Antagonist Major Product Offerings
7.10.4 Kaleo Pharma Opiate Antagonist Revenue in Global Market (2018-2023)
7.10.5 Kaleo Pharma Key News & Latest Developments
7.11 Mylan Institutional
7.11.1 Mylan Institutional Company Summary
7.11.2 Mylan Institutional Business Overview
7.11.3 Mylan Institutional Opiate Antagonist Major Product Offerings
7.11.4 Mylan Institutional Opiate Antagonist Revenue in Global Market (2018-2023)
7.11.5 Mylan Institutional Key News & Latest Developments
7.12 Perrigo Pharmaceuticals
7.12.1 Perrigo Pharmaceuticals Company Summary
7.12.2 Perrigo Pharmaceuticals Business Overview
7.12.3 Perrigo Pharmaceuticals Opiate Antagonist Major Product Offerings
7.12.4 Perrigo Pharmaceuticals Opiate Antagonist Revenue in Global Market (2018-2023)
7.12.5 Perrigo Pharmaceuticals Key News & Latest Developments
7.13 AuroMedics Pharma
7.13.1 AuroMedics Pharma Company Summary
7.13.2 AuroMedics Pharma Business Overview
7.13.3 AuroMedics Pharma Opiate Antagonist Major Product Offerings
7.13.4 AuroMedics Pharma Opiate Antagonist Revenue in Global Market (2018-2023)
7.13.5 AuroMedics Pharma Key News & Latest Developments
7.14 Somerset Pharma
7.14.1 Somerset Pharma Company Summary
7.14.2 Somerset Pharma Business Overview
7.14.3 Somerset Pharma Opiate Antagonist Major Product Offerings
7.14.4 Somerset Pharma Opiate Antagonist Revenue in Global Market (2018-2023)
7.14.5 Somerset Pharma Key News & Latest Developments
7.15 Akorn
7.15.1 Akorn Company Summary
7.15.2 Akorn Business Overview
7.15.3 Akorn Opiate Antagonist Major Product Offerings
7.15.4 Akorn Opiate Antagonist Revenue in Global Market (2018-2023)
7.15.5 Akorn Key News & Latest Developments
7.16 Alkermes
7.16.1 Alkermes Company Summary
7.16.2 Alkermes Business Overview
7.16.3 Alkermes Opiate Antagonist Major Product Offerings
7.16.4 Alkermes Opiate Antagonist Revenue in Global Market (2018-2023)
7.16.5 Alkermes Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Opiate Antagonist Market Opportunities & Trends in Global Market
Table 2. Opiate Antagonist Market Drivers in Global Market
Table 3. Opiate Antagonist Market Restraints in Global Market
Table 4. Key Players of Opiate Antagonist in Global Market
Table 5. Top Opiate Antagonist Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Opiate Antagonist Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Opiate Antagonist Revenue Share by Companies, 2018-2023
Table 8. Global Companies Opiate Antagonist Product Type
Table 9. List of Global Tier 1 Opiate Antagonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opiate Antagonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Opiate Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Opiate Antagonist Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Opiate Antagonist Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Opiate Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Opiate Antagonist Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Opiate Antagonist Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Opiate Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Opiate Antagonist Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Opiate Antagonist Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Opiate Antagonist Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Opiate Antagonist Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Opiate Antagonist Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Opiate Antagonist Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Opiate Antagonist Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Opiate Antagonist Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Opiate Antagonist Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Opiate Antagonist Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Opiate Antagonist Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Opiate Antagonist Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Opiate Antagonist Product Offerings
Table 32. Pfizer Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Sun Pharmaceutical Industries Company Summary
Table 35. Sun Pharmaceutical Industries Opiate Antagonist Product Offerings
Table 36. Sun Pharmaceutical Industries Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 37. Sun Pharmaceutical Industries Key News & Latest Developments
Table 38. Teva Pharmaceuticals Company Summary
Table 39. Teva Pharmaceuticals Opiate Antagonist Product Offerings
Table 40. Teva Pharmaceuticals Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pharmaceuticals Key News & Latest Developments
Table 42. Cardinal Health Company Summary
Table 43. Cardinal Health Opiate Antagonist Product Offerings
Table 44. Cardinal Health Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 45. Cardinal Health Key News & Latest Developments
Table 46. Baxter Pharmaceutical Company Summary
Table 47. Baxter Pharmaceutical Opiate Antagonist Product Offerings
Table 48. Baxter Pharmaceutical Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 49. Baxter Pharmaceutical Key News & Latest Developments
Table 50. Adapt Pharmaceuticals Company Summary
Table 51. Adapt Pharmaceuticals Opiate Antagonist Product Offerings
Table 52. Adapt Pharmaceuticals Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 53. Adapt Pharmaceuticals Key News & Latest Developments
Table 54. Dr. Reddy's Laboratories Company Summary
Table 55. Dr. Reddy's Laboratories Opiate Antagonist Product Offerings
Table 56. Dr. Reddy's Laboratories Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 57. Dr. Reddy's Laboratories Key News & Latest Developments
Table 58. GIV Repack Company Summary
Table 59. GIV Repack Opiate Antagonist Product Offerings
Table 60. GIV Repack Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 61. GIV Repack Key News & Latest Developments
Table 62. Intl Medication Systems Company Summary
Table 63. Intl Medication Systems Opiate Antagonist Product Offerings
Table 64. Intl Medication Systems Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 65. Intl Medication Systems Key News & Latest Developments
Table 66. Kaleo Pharma Company Summary
Table 67. Kaleo Pharma Opiate Antagonist Product Offerings
Table 68. Kaleo Pharma Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 69. Kaleo Pharma Key News & Latest Developments
Table 70. Mylan Institutional Company Summary
Table 71. Mylan Institutional Opiate Antagonist Product Offerings
Table 72. Mylan Institutional Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 73. Mylan Institutional Key News & Latest Developments
Table 74. Perrigo Pharmaceuticals Company Summary
Table 75. Perrigo Pharmaceuticals Opiate Antagonist Product Offerings
Table 76. Perrigo Pharmaceuticals Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 77. Perrigo Pharmaceuticals Key News & Latest Developments
Table 78. AuroMedics Pharma Company Summary
Table 79. AuroMedics Pharma Opiate Antagonist Product Offerings
Table 80. AuroMedics Pharma Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 81. AuroMedics Pharma Key News & Latest Developments
Table 82. Somerset Pharma Company Summary
Table 83. Somerset Pharma Opiate Antagonist Product Offerings
Table 84. Somerset Pharma Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 85. Somerset Pharma Key News & Latest Developments
Table 86. Akorn Company Summary
Table 87. Akorn Opiate Antagonist Product Offerings
Table 88. Akorn Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 89. Akorn Key News & Latest Developments
Table 90. Alkermes Company Summary
Table 91. Alkermes Opiate Antagonist Product Offerings
Table 92. Alkermes Opiate Antagonist Revenue (US$, Mn) & (2018-2023)
Table 93. Alkermes Key News & Latest Developments
List of Figures
Figure 1. Opiate Antagonist Segment by Type in 2022
Figure 2. Opiate Antagonist Segment by Application in 2022
Figure 3. Global Opiate Antagonist Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Opiate Antagonist Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Opiate Antagonist Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opiate Antagonist Revenue in 2022
Figure 8. By Type - Global Opiate Antagonist Revenue Market Share, 2018-2029
Figure 9. By Application - Global Opiate Antagonist Revenue Market Share, 2018-2029
Figure 10. By Type - Global Opiate Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Opiate Antagonist Revenue Market Share, 2018-2029
Figure 12. By Application - Global Opiate Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Opiate Antagonist Revenue Market Share, 2018-2029
Figure 14. By Region - Global Opiate Antagonist Revenue Market Share, 2018-2029
Figure 15. By Country - North America Opiate Antagonist Revenue Market Share, 2018-2029
Figure 16. US Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Opiate Antagonist Revenue Market Share, 2018-2029
Figure 20. Germany Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 21. France Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Opiate Antagonist Revenue Market Share, 2018-2029
Figure 28. China Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 32. India Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Opiate Antagonist Revenue Market Share, 2018-2029
Figure 34. Brazil Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Opiate Antagonist Revenue Market Share, 2018-2029
Figure 37. Turkey Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Opiate Antagonist Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sun Pharmaceutical Industries Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pharmaceuticals Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cardinal Health Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Baxter Pharmaceutical Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Adapt Pharmaceuticals Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dr. Reddy's Laboratories Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GIV Repack Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Intl Medication Systems Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Kaleo Pharma Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mylan Institutional Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Perrigo Pharmaceuticals Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. AuroMedics Pharma Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Somerset Pharma Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Akorn Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Alkermes Opiate Antagonist Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ オピエートきっ抗剤の世界市場見通し2023年-2029年(Opiate Antagonist Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

オピエートきっ抗剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp